These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 15956822)

  • 1. Endothelial dysfunction: its role in hypertensive coronary disease.
    Bolad I; Delafontaine P
    Curr Opin Cardiol; 2005 Jul; 20(4):270-4. PubMed ID: 15956822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelial dysfunction in essential hypertension.
    Panza JA
    Clin Cardiol; 1997 Nov; 20(11 Suppl 2):II-26-33. PubMed ID: 9422849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelial dysfunction in hypertension.
    Puddu P; Puddu GM; Zaca F; Muscari A
    Acta Cardiol; 2000 Aug; 55(4):221-32. PubMed ID: 11041120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The L-arginine-nitric oxide pathway in hypertension.
    Kelm M
    Curr Hypertens Rep; 2003 Feb; 5(1):80-6. PubMed ID: 12530940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of nebivolol on blood oxygen transport indices and endothelial dysfunction in patients with arterial hypertension.
    Pronko TP; Zinchuk VV
    Clin Physiol Funct Imaging; 2009 May; 29(3):170-6. PubMed ID: 19170724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelial dysfunction, ADMA and insulin resistance in essential hypertension.
    Perticone F; Sciacqua A; Maio R; Perticone M; Galiano Leone G; Bruni R; Di Cello S; Pascale A; Talarico G; Greco L; Andreozzi F; Sesti G
    Int J Cardiol; 2010 Jul; 142(3):236-41. PubMed ID: 19168237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic administration of sodium nitrite prevents hypertension and protects arterial endothelial function by reducing oxidative stress in angiotensin II-infused mice.
    Ling WC; Mustafa MR; Vanhoutte PM; Murugan DD
    Vascul Pharmacol; 2018 Mar; 102():11-20. PubMed ID: 28552746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypertension and endothelial dysfunction: therapeutic approach.
    Ghiadoni L; Taddei S; Virdis A
    Curr Vasc Pharmacol; 2012 Jan; 10(1):42-60. PubMed ID: 22112351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Xin-Ji-Er-Kang formula on 2K1C-induced hypertension and cardiovascular remodeling in rats.
    Guo K; Lan CZ; Yu TT; Huang LL; Wang XH; Pan C; Gao S
    J Ethnopharmacol; 2014 Sep; 155(2):1227-35. PubMed ID: 25063306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical importance of coronary endothelial vasodilator dysfunction and therapeutic options.
    Britten MB; Zeiher AM; Schächinger V
    J Intern Med; 1999 Apr; 245(4):315-27. PubMed ID: 10356593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma asymmetric dimethylarginine and coronary and peripheral endothelial dysfunction in hypertensive patients.
    Takiuchi S; Fujii H; Kamide K; Horio T; Nakatani S; Hiuge A; Rakugi H; Ogihara T; Kawano Y
    Am J Hypertens; 2004 Sep; 17(9):802-8. PubMed ID: 15363823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcium channel blockers, endothelial dysfunction, and combination therapy.
    Schulman IH; Zachariah M; Raij L
    Aging Clin Exp Res; 2005 Aug; 17(4 Suppl):40-5. PubMed ID: 16640172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nebivolol treatment reduces serum levels of asymmetric dimethylarginine and improves endothelial dysfunction in essential hypertensive patients.
    Pasini AF; Garbin U; Stranieri C; Boccioletti V; Mozzini C; Manfro S; Pasini A; Cominacini M; Cominacini L
    Am J Hypertens; 2008 Nov; 21(11):1251-7. PubMed ID: 18772860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of sustained-release-L-arginine formulation on blood pressure and vascular compliance in 29 healthy individuals.
    Miller AL
    Altern Med Rev; 2006 Mar; 11(1):23-9. PubMed ID: 16597191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resveratrol prevents endothelial nitric oxide synthase uncoupling and attenuates development of hypertension in spontaneously hypertensive rats.
    Bhatt SR; Lokhandwala MF; Banday AA
    Eur J Pharmacol; 2011 Sep; 667(1-3):258-64. PubMed ID: 21640096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Curcumin improves endothelial dysfunction and vascular remodeling in 2K-1C hypertensive rats by raising nitric oxide availability and reducing oxidative stress.
    Boonla O; Kukongviriyapan U; Pakdeechote P; Kukongviriyapan V; Pannangpetch P; Prachaney P; Greenwald SE
    Nitric Oxide; 2014 Nov; 42():44-53. PubMed ID: 25194767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Asymmetric dimethylarginine, L-arginine, and endothelial dysfunction in essential hypertension.
    Perticone F; Sciacqua A; Maio R; Perticone M; Maas R; Boger RH; Tripepi G; Sesti G; Zoccali C
    J Am Coll Cardiol; 2005 Aug; 46(3):518-23. PubMed ID: 16053968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Raloxifene improves endothelial dysfunction in hypertension by reduced oxidative stress and enhanced nitric oxide production.
    Wassmann S; Laufs U; Stamenkovic D; Linz W; Stasch JP; Ahlbory K; Rösen R; Böhm M; Nickenig G
    Circulation; 2002 Apr; 105(17):2083-91. PubMed ID: 11980689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of ATP-sensitive potassium channels protects vascular endothelial cells from hypertension and renal injury induced by hyperuricemia.
    Long CL; Qin XC; Pan ZY; Chen K; Zhang YF; Cui WY; Liu GS; Wang H
    J Hypertens; 2008 Dec; 26(12):2326-38. PubMed ID: 19008712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial dysfunction in spontaneously hypertensive rats: consequences of chronic treatment with losartan or captopril.
    Rodrigo E; Maeso R; Muñoz-García R; Navarro-Cid J; Ruilope LM; Cachofeiro V; Lahera V
    J Hypertens; 1997 Jun; 15(6):613-8. PubMed ID: 9218180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.